Recombinant TNFSF4 (Oxelumab Biosimilar) antibody

Catalog No. ABIN5668178

This Human Monoclonal antibody specifically detects TNFSF4 (Oxelumab Biosimilar) in FACS and BR. It exhibits reactivity toward Human.

Quick Overview for Recombinant TNFSF4 (Oxelumab Biosimilar) antibody (ABIN5668178)

Target: TNFSF4 (Oxelumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TNFSF4 (Oxelumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Blocking Reagent (BR)

Clone: R4930

Product Details anti-TNFSF4 (Oxelumab Biosimilar) Antibody

Purpose: Anti-OX40L [R4930 (Oxelumab)], Human IgG1, kappa

Specificity: Binds to human OX40L.

Characteristics:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Purity: > 98 % as determined by SDS-PAGE

Endotoxin Level: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.

Isotype: IgG1 kappa

Application Details

Application Notes: This antibody binds to the co-stimulatory OX40L, inhibiting its interaction with OX40.

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for TNFSF4 (Oxelumab Biosimilar)

Target: TNFSF4 (Oxelumab Biosimilar)

Target Type: Biosimilar

Background: CD252, TNFSF4, tumor necrosis factor (TNF) superfamily member 4, OX40 ligand, OX-40L, TAX transcriptionally-activated glycoprotein 1, TXGP1, gp34

UniProt: P23510